Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure

Figure 1

(a) MMP-9, (b) TIMP-4, and (c) BNP blood levels in SSc patients with diffuse (dSSc) and limited (lSSc) skin involvement as well as in those patients with pulmonary fibrosis (PF+) compared to healthy controls (Mann-Whitney test, NS denotes nonsignificant).

(a)

(b)

(c)